A. E. CRAWLEY

613 total citations
13 papers, 182 citations indexed

About

A. E. CRAWLEY is a scholar working on Pharmacology, Geriatrics and Gerontology and Psychiatry and Mental health. According to data from OpenAlex, A. E. CRAWLEY has authored 13 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Geriatrics and Gerontology and 4 papers in Psychiatry and Mental health. Recurrent topics in A. E. CRAWLEY's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Asthma and respiratory diseases (3 papers) and Respiratory and Cough-Related Research (2 papers). A. E. CRAWLEY is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Asthma and respiratory diseases (3 papers) and Respiratory and Cough-Related Research (2 papers). A. E. CRAWLEY collaborates with scholars based in Canada, United States and Switzerland. A. E. CRAWLEY's co-authors include David Blackburn, Mark Lemstra, Laura Murphy, Rejina Kamrul, Jeff Taylor, Kerry Mansell, Charity Evans, Tessa Laubscher, Qais Alefan and Donna Goodridge and has published in prestigious journals such as Canadian Journal of Cardiology, Journal of the American Pharmacists Association and Journal of Pharmacy Practice.

In The Last Decade

A. E. CRAWLEY

10 papers receiving 177 citations

Peers

A. E. CRAWLEY
Julio Lopez United States
John E. Byrd United States
Carel Bakx Netherlands
Kirsi Norrbacka United States
Christie Schumacher United States
Eberta Tan Singapore
Julio Lopez United States
A. E. CRAWLEY
Citations per year, relative to A. E. CRAWLEY A. E. CRAWLEY (= 1×) peers Julio Lopez

Countries citing papers authored by A. E. CRAWLEY

Since Specialization
Citations

This map shows the geographic impact of A. E. CRAWLEY's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. CRAWLEY with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. CRAWLEY more than expected).

Fields of papers citing papers by A. E. CRAWLEY

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. CRAWLEY. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. CRAWLEY. The network helps show where A. E. CRAWLEY may publish in the future.

Co-authorship network of co-authors of A. E. CRAWLEY

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. CRAWLEY. A scholar is included among the top collaborators of A. E. CRAWLEY based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. CRAWLEY. A. E. CRAWLEY is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
CRAWLEY, A. E., et al.. (2023). Thoughtful prescribing for patients with difficult-to-treat depression. Canadian Family Physician. 69(11). 777–783.
2.
CRAWLEY, A. E., et al.. (2023). Improper administration. Canadian Family Physician. 69(2). 107–112.
3.
CRAWLEY, A. E., et al.. (2023). Une administration inappropriée. Canadian Family Physician. 69(2). e38–e44. 1 indexed citations
4.
CRAWLEY, A. E., et al.. (2022). L’asthme léger chez les adultes et les adolescents. Canadian Family Physician. 68(8). e248–e251. 1 indexed citations
5.
CRAWLEY, A. E., et al.. (2021). Prise en charge pharmacothérapeutique de la schizophrénie à l’intention des médecins de famille. Canadian Family Physician. 67(5). e115–e120.
6.
CRAWLEY, A. E., et al.. (2021). Pharmacotherapy management of schizophrenia for family physicians. Canadian Family Physician. 67(5). 350–354. 3 indexed citations
7.
Alefan, Qais, et al.. (2020). Evaluation of a medication safety and adherence program within a First Nations community in Saskatchewan, Canada. Journal of the American Pharmacists Association. 61(1). e39–e45. 2 indexed citations
8.
Kamrul, Rejina, et al.. (2019). Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.. Europe PMC (PubMed Central). 65(11). 807–811. 7 indexed citations
9.
Blackburn, David, Sharyle Fowler, A. E. CRAWLEY, et al.. (2019). An Advanced Pharmacy Practice Experience for Community Pharmacies Based on a Clinical Intervention Targeting Patients With Inflammatory Bowel Disease. Journal of Pharmacy Practice. 34(1). 51–57. 2 indexed citations
10.
CRAWLEY, A. E., et al.. (2018). Tapering opioids using motivational interviewing.. PubMed. 64(8). 584–587. 9 indexed citations
11.
CRAWLEY, A. E., et al.. (2016). Pharmacologic management of COPD: Breadth of products for encouraging a breath of air.. PubMed. 62(5). 410–4. 1 indexed citations
12.
Lemstra, Mark, et al.. (2012). Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis. Canadian Journal of Cardiology. 28(5). 574–580. 155 indexed citations
13.
CRAWLEY, A. E.. (2006). The Tree of Life; A Study of Religion. Bulletin of Miscellaneous Information (Royal Gardens Kew). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026